Scott Wolchko | President and CEO |
Chris Storgard | Chief Medical Officer |
Dan Shoemaker | Chief Scientific Officer |
David Nierengarten | Wedbush Securities |
Do Kim | BMO Capital Markets |
ED White | H.C. Wainwright |
Welcome to Fate Therapeutics Third Quarter 2017 Financial Results Conference Call. [Operator Instructions]. I would now like to introduce Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.
Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics third quarter 2017 financial results call.